Breast Cancer
Conditions
Keywords
Breast Cancer
Brief summary
This study is focused on understanding how the investigators can improve upon breast cancer and health outcomes for older participants with breast cancer.
Detailed description
This study is focused on understanding how the investigators can improve upon breast cancer and health outcomes for older participants with breast cancer, a group of participants who often have low risk cancers, but who may do worse than younger participants with the same kind of cancers. Researchers want to better understand the experiences, barriers, and changes in physical function older participants with breast cancer have.
Interventions
BEHAVIORALObservational cohort
Patients will be followed by collecting clinical data, biospecimens, and quality of life assessments over a period of five years from registration.
Sponsors
Susan G. Komen Breast Cancer Foundation
Dana-Farber Cancer Institute
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
70 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age 70 or older at the time of diagnosis (as indicated by the date of breast biopsy) * No more than 67 patients (1/3) will be aged 70-74, with the remaining patients on study ages 75 or older * Any gender is eligible * Invasive, non-metastatic breast cancer at diagnosis * Those with prior diagnoses of pre-invasive (DCIS) or invasive breast cancer are eligible as long as their current diagnosis is felt by the treating provider to represent a NEW non-metastatic primary invasive breast cancer (e.g. someone with a nodal recurrence from prior disease are not eligible but those with a new contralateral breast cancer 3 years after a first breast cancer would be eligible) * Any breast cancer subtype is allowed * Breast cancer-diagnosing biopsy within 90 days of enrollment * Receiving or will receive medical oncology care (+/- surgical and radiation oncology treatments) at the participating center: DFCI/satellites and affiliate sites * Patients must be able to understand, speak, and read English or assign a designated caregiver/proxy for the duration of the study who understands, speaks, and reads English and who is willing to assist with filling out the survey components which do not have a validated, translated version. This is because the surveys are not readily available in multiple languages as a whole, although some components (such as the Geriatric Assessment and PROs are readily available in multiple languages). * If a patient scores 11 or higher on the baseline Orientation-Memory-Concentration Test done at baseline (Appendix E), a proxy/designee must then be assigned to help the patient fill out the questionnaires for the duration of the study in order to participate. The treating provider will also be notified about the cognitive impairment. * Ability to provide informed consent
Exclusion criteria
* Pathological or clinical stage 0, IV disease * Those with nodal or metastatic recurrences at the time of enrollment * Unable to speak and read English AND no designee who speaks and reads English, as above * Unable to provide informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Adjuvant treatment recommendations | 7 years | Report treatment recommendations made to patients enrolled on the cohort |
| Adherence to hormonal therapy | 7 years | We will survey patients on adherence |
| Barriers to treatment and adherence | 7 years | We will survey patients on the reasons for adherence and poor adherence |
| Treatment patterns by age and other characteristics | 7 years | We will examine treatment receipt and patterns by subtype of disease |
Countries
United States
Outcome results
None listed